Design & Process improvement

Slide background

GMP Compliance & Audits

Experience

A balanced approach between continuous improvement and GMP compliance and extensive consultancy experience. Look at our  references.

Science & risk based

We apply a science & risk based approach to every project we deliver . Look at the  services  description or  simply tell us what you need.

We team up

We join your technical team providing value and knowledge. We have experience in project management even in multisite, international environments.

SMART QbD

Discover SMART QbD™, a proven and comprehensive methodology to support your Quality by Design projects.

Contact us

Privacy Policy   info

Legal Notice    info

QbD Pharmaceutical Services S.L – NIF: B66578030  C/ Mascaró 62 BARCELONA 08032   info@qualitybydesign.es

“On behalf of the company, we treat the information you provide to us in order to send you advertising related to our products and services by any means (postal, email or telephone), and invite you to events organized by the company in the meanwhile you do not request the cessation of activity.

The data will not be transferred to third parties except in cases where there is a legal obligation. You have the right to obtain confirmation on whether QbD Pharmaceutical Services SL is treating your personal data therefore you have the right to access to your personal data, rectify inaccurate data or request its deletion when the data is no longer necessary for the purposes that were collected “

ICH Q12 o la consolidación del Quality by Design

  En diciembre de 2017 acaba de publicarse la largamente esperada ICH Q12. Está en periodo de consulta pública, que se prolongará durante un año, lo cual da una idea de la envergadura del cambio que supone. La ICH Q12 viene a cerrar el círculo del Quality by Design. Su objetivo es plantear un sistema de […]

Novedades del Anexo 1 EU GMP

Finalmente, habiendo transcurrido más de 10 años desde la última revisión, y después de casi 3 años de su respectivo anuncio, el pasado 20 de diciembre el nuevo anexo 1 de las EU GMP ha sido publicado en forma de borrador. El período de consulta durará 3 meses y se extenderá hasta el 20 de […]